News & Events

The American Congress of Obstetricians and Gynecologists (ACOG) awarded a Viveve-sponsored abstract, titled “Nonsurgical Radiofrequency Treatment for Laxity of the Vaginal Introitus: 6-Month Data” a blue ribbon signifying the abstract received the highest rankings in its category. The award winning abstract was presented as a poster at the 58^th Annual ACOG meeting held in San Francisco May 15^th-19^th of this year.

“This award is quite an honor,” said Dr. Seth J. Herbst, the lead author on the abstract, principal investigator on the study and OB/GYN at the Institute of Women’s Health, West Palm Beach, Florida. “Only 15 abstracts out of 279 accepted for poster presentations were selected to receive this designation and I’m delighted for the recognition of this very important study.”

The IRB approved study, sponsored by Viveve, was a first of its kind study on the novel use of a medical device to treat vaginal laxity post childbirth to improve a woman’s physical sensation and sexual satisfaction during intercourse. “We’re excited that the 6-month results of this study show great promise for the Viveve procedure,” said Kerry Pope, chief executive of Viveve. “We’re also very pleased with the award and would like to thank the authors for their work on the study and the abstract and ACOG for the recognition to this important topic in women’s sexual health.”